Mig-6 regulates endometrial genes involved in cell cycle and progesterone signaling.

[1]  H. Martha,et al.  Endometriosis , 2015 .

[2]  R. Broaddus,et al.  Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer. , 2013, Cancer research.

[3]  R. Lanz,et al.  Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. , 2012, Molecular endocrinology.

[4]  R. Behringer,et al.  Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  L. Giudice,et al.  Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. , 2011, The Journal of clinical endocrinology and metabolism.

[6]  J. Qin,et al.  The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression , 2010, Oncogene.

[7]  Jae-Wook Jeong,et al.  ERBB Receptor Feedback Inhibitor 1 Regulation of Estrogen Receptor Activity Is Critical for Uterine Implantation in Mice1 , 2010, Biology of reproduction.

[8]  L. D. White,et al.  Ablation of Indian Hedgehog in the Murine Uterus Results in Decreased Cell Cycle Progression, Aberrant Epidermal Growth Factor Signaling, and Increased Estrogen Signaling1 , 2010, Biology of reproduction.

[9]  J. Kim,et al.  Role of Progesterone in Endometrial Cancer , 2010, Seminars in reproductive medicine.

[10]  L. D. White,et al.  Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease , 2009, Proceedings of the National Academy of Sciences.

[11]  K. Lee,et al.  Conservative Treatment With Progestin and Pregnancy Outcomes in Endometrial Cancer , 2009, International Journal of Gynecologic Cancer.

[12]  J. Kim,et al.  Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report. , 2008, The Journal of reproductive medicine.

[13]  Jin-fang Lin,et al.  Reverse of Progestin-Resistant Atypical Endometrial Hyperplasia by Metformin and Oral Contraceptives , 2008, Obstetrics and gynecology.

[14]  J. Merchant,et al.  A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion , 2007, FEBS letters.

[15]  R. Broaddus,et al.  Generation of a Mig‐6 conditional null allele , 2007, Genesis.

[16]  H. Ishikura,et al.  Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. , 2007, Human reproduction.

[17]  R. Bronson,et al.  Evidence that MIG-6 is a tumor-suppressor gene , 2007, Oncogene.

[18]  S. Dunwoodie,et al.  Generation of conditional Cited2 null alleles , 2006, Genesis.

[19]  Yu-Chung Yang,et al.  Post-transcriptional Control of Cited2 by Transforming Growth Factor β , 2006, Journal of Biological Chemistry.

[20]  J. V. Vanden Heuvel,et al.  Examination of Ligand-Dependent Coactivator Recruitment by Peroxisome Proliferator-Activated Receptor-α (PPARα) , 2006, PPAR research.

[21]  Yan Wu,et al.  Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Endometriosis , 2006, Epigenetics.

[22]  L. D. White,et al.  Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. , 2005, Endocrinology.

[23]  J. Li,et al.  Cre‐mediated recombination in cell lineages that express the progesterone receptor , 2005, Genesis.

[24]  Jeff Reese,et al.  Molecular cues to implantation. , 2004, Endocrine reviews.

[25]  J. Lydon,et al.  Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms , 2003, Steroids.

[26]  Joyce Cheung-Flynn,et al.  The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. , 2003, Endocrinology.

[27]  S. Tsai,et al.  Mechanisms of Action of Estrogen and Progesterone , 2002, Annals of the New York Academy of Sciences.

[28]  Jennifer N. Murdoch,et al.  Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator , 2001, Nature Genetics.

[29]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. O’Malley,et al.  Reproductive phenotypes of the progesterone receptor null mutant mouse , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[31]  B. O’Malley,et al.  Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. , 1995, Genes & development.

[32]  S. Kennedy.  Endometriosis , 1992, The Lancet.

[33]  C. Clarke,et al.  Progestin regulation of cellular proliferation. , 1990, Endocrine reviews.

[34]  G. Sutton,et al.  Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. , 1988, American journal of obstetrics and gynecology.

[35]  K. Korach,et al.  The Influence of 17β-Estradiol on Patterns of Cell Division in the Uterus , 1984 .

[36]  R. M. Das,et al.  The inhibition by progesterone of uterine epithelial proliferation in the mouse. , 1973, The Journal of endocrinology.

[37]  L. Martin,et al.  Endocrine control of the timing of endometrial sensitivity to a decidual stimulus. , 1972, Biology of reproduction.

[38]  K. Korach,et al.  The influence of 17 beta-estradiol on patterns of cell division in the uterus. , 1984, Endocrinology.

[39]  G. Berri.  [Cardiac malformations]. , 1965, Archivos argentinos de pediatria.